Marshall Wace North America’s Immunomedics Inc IMMU Stock Holding History

Marshall Wace North America’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-36,044	Closed	-$3.06M	–	1722
2020 Q3	$3.06M	Sell	36,044 -2,565,120	-99%	-$130M	0.02%	483
2020 Q2	$92.2M	Buy	2,601,164 +2,079,733	+399%	+$60.8M	0.61%	34
2020 Q1	$7.03M	Buy	521,431 +498,916	+2,216%	+$8.39M	0.05%	266
2019 Q4	$476K	Buy	+22,515	New	+$397K	﹤0.01%	834
2019 Q1	–	Sell	-18,555	Closed	-$265K	–	2054
2018 Q4	$265K	Buy	+18,555	New	+$368K	﹤0.01%	902
2018 Q3	–	Sell	-23,411	Closed	-$554K	–	1557
2018 Q2	$554K	Sell	23,411 -133,455	-85%	-$2.68M	﹤0.01%	1064
2018 Q1	$2.29M	Sell	156,866 -321,946	-67%	-$5.26M	0.01%	778
2017 Q4	$7.74M	Buy	+478,812	New	+$5.65M	0.04%	454

Marshall Wace North America's IMMU Position: Q4 2020 in Review

Marshall Wace North America sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 36,044 shares — an estimated $3.06M sold.

Marshall Wace North America first reported a position in IMMU in Q4 2017 and held it in 8 quarters. The position peaked at $92.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Marshall Wace North America reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 36,044 Immunomedics Inc shares in Q4 2020, an estimated $3.06M.
Marshall Wace North America first reported a position in Immunomedics Inc in Q4 2017 and held it in 8 quarters.
Marshall Wace North America's Immunomedics Inc position peaked at $92.2M in Q2 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.